Navigation Links
The Only Chromogenic Medium That Detects Both Salmonella and Shigella!
Date:2/14/2011

ure and identification of bacteria and fungi from its Santa Maria, California headquarters. Currently over 6,000 laboratories are serviced by Hardy Diagnostics throughout the nation.

The company was founded in 1980 by Jay Hardy, a Clinical Laboratory Scientist from Santa Barbara, CA. Today, Hardy Diagnostics maintains six distribution centers throughout the U.S. and exports products to over 30 foreign distributors.

The company's mission is to partner with its laboratory customers to prevent and diagnose disease. For more information, visit http://www.HardyDiagnostics.com/HardyChromSS.htmlContact Information:Contact Person: Christopher CataniCompany Name: HARDY DIAGNOSTICSAddress: 1430 West McCoy Lane, Santa Maria, CA 93455Phone Number: (805) 346-2766, Ext: 5696Fax Number: (805) 928-2950Email Address: CataniC@HardyDiagnostics.comCompany Website: http://www.HardyDiagnostics.com/HardyChromSS.html
'/>"/>

SOURCE Hardy Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Chromogenic Endotoxin Detection System
2. QualTech Laboratories Validates USP Protocols for Anti-Factor IIa Chromogenic Assay for Potency
3. eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals
4. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
5. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
6. PharMEDium Elects William R. Spalding to Board of Directors
7. Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam
8. New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects
9. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
10. Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium
11. American Heart Association Rapid Access Journal Report: Implanted Monitor Accurately Detects Heart Rhythm Disturbances
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... MENLO PARK, Calif. , April 1, 2015 ... ("DelMar" and the "Company"), today announced that it has ... R.Psych., to its Board of Directors as an independent ... decades of biotechnology experience in executive leadership roles as ... member, including serving as the chairman of a leading ...
(Date:3/31/2015)... , March 31, 2015 Neurocrine Biosciences, Inc. ... entered into an exclusive collaboration and licensing agreement for ... in Japan and other select ... Mitsubishi Tanabe intends to initially develop NBI-98854 in ... Huntington,s disease and tardive dyskinesia. Neurocrine retains full commercial ...
(Date:3/31/2015)... , March 31, 2015 ... the multidisciplinary confocal laser endomicroscopy platform, today announced the ... de Grenoble (university hospital center). The CHU de Grenoble ... to propose to its gastroenterology, interventional pulmonology ... and a higher standard of care thanks to the ...
Breaking Medicine Technology:DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 2DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 3DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 4Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 2Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 3Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement to Develop and Commercialize VMAT2 Inhibitor NBI-98854 for Movement Disorders in Japan and Other Select Asian Markets 4Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 2Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 3
... Reportlinker.com announces that a new market research report is available ... http://www.reportlinker.com/p0324750/Virtual-Pharma.html ... in the pharmaceutical market has slowed – almost to a ... cutting costs in a faltering world economy. ...
... NEW YORK, Nov. 3, 2010 Pfizer Inc. (NYSE: ... public to view and listen to a webcast of ... Primary Care, at the 2010 Annual Credit Suisse Healthcare ... Mountain Standard Time. (Logo: http://photos.prnewswire.com/prnh/20100416/PFIZERLOGO) ...
Cached Medicine Technology:Reportlinker Adds Virtual Pharma 2Reportlinker Adds Virtual Pharma 3Reportlinker Adds Virtual Pharma 4Reportlinker Adds Virtual Pharma 5Reportlinker Adds Virtual Pharma 6
(Date:4/1/2015)... Health Advocate™, Inc., the nation’s leading healthcare ... Corporation, today launched its new Health and Wellness Blog. ... the Health Advocate member website, features timely and reliable ... , “We’re pleased to introduce this new blog and ... Rosen, Executive Vice President, Health Advocate. “The blog is ...
(Date:4/1/2015)... Boys & Girls Clubs of America (BGCA) and ... education, today announced at a press conference with Georgia ... that the organizations will work together for their third ... instruction to thousands of children across the country through ... swimming-safety instruction to more than 2,500 Club members at ...
(Date:4/1/2015)... Dallas, Texas (PRWEB) April 01, 2015 ... Global Atorvastatin Calcium Industry is a professional and ... global Atorvastatin Calcium Market with a ... included in atorvastatin calcium market research are Pfizer, ... Laboratories Ltd, Sinochem Pharmaceuticals India Private Limited, Cadila ...
(Date:4/1/2015)... Skin cancer is one of the most ... early. Forefront Dermatology and Dermatology Associates of Wisconsin want to ... it spreads so they are hosting a free skin cancer ... - 12:30pm. , “If we can see the early ... that could become cancerous,” said Dr. Ken Katz, who is ...
(Date:4/1/2015)... Columbus, OH (PRWEB) April 01, 2015 ... adults, is proud to announce the establishment of the ... The scholarship is made possible through the generous gift ... presented the gift on behalf of Medical Mutual to ... Bonnie Quist, Vice President of Advancement & Strategic Relations. ...
Breaking Medicine News(10 mins):Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Boys & Girls Clubs of America and The ZAC Foundation Announce Third Year of National Partnership to Bring Water Safety Education to 20 Cities Across the Country 2Health News:Boys & Girls Clubs of America and The ZAC Foundation Announce Third Year of National Partnership to Bring Water Safety Education to 20 Cities Across the Country 3Health News:Boys & Girls Clubs of America and The ZAC Foundation Announce Third Year of National Partnership to Bring Water Safety Education to 20 Cities Across the Country 4Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 3Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 2Health News:Franklin University Receives Gift to Create the Greta J. Russell Medical Mutual of Ohio Scholarship 3
... ... 70 Percent, IRVINE, Calif., Oct. 31 Endocare, Inc.,(Nasdaq: ... the,development of minimally invasive technologies for tissue and tumor,ablation, reported ... margins resulted in a reduction,in operating loss in the third ...
... StemCor Systems, Inc., a,medical device company developing ... it has received 510(k) clearance from,the U.S. ... its MarrowMiner(TM),for the harvest of bone marrow. ... clearance of StemCor,s MarrowMiner is a major,accomplishment ...
... Statistical Significance, IRVINE, Calif., Oct. 30 ... Biotech, today,announced that the Phase 3 SPARC trial ... did not meet its primary,efficacy endpoint. "We ... for,satraplatin did not achieve statistical significance. Drug development ...
... NY) Researchers at the Albert Einstein College of ... time that cancers can be successfully treated by targeting ... in the October 31 issue of PloS One, also ... cells before they turn cancerous. , The Einstein researchers ...
... Corporation,(Nasdaq and OMX Nordic Exchange: EPCT) today announced that ... Acumen BioFin Rodman & Renshaw,9th Annual Healthcare Conference on ... New York Palace Hotel in New York. Mr. Talley ... ) The presentation will be available live via ...
... Oct. 30 Florida already allows it. And new,research ... the,authority to independently prescribe prescription drugs, a move which ... in 2006 to,$145 billion by 2012, according to Prescribing ... Information. The study shows that 77% of drug ...
Cached Medicine News:Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 2Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 3Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 4Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 5Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 6Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 7Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 8Health News:Endocare Reports 2007 Third Quarter and Nine-Month Results 9Health News:StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System 2Health News:StemCor Systems Receives FDA Clearance for Bone Marrow Harvesting System 3Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 2Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 3Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 2Health News:Einstein scientists treat cancer as an infectious disease -- with promising results 3Health News:EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3Health News:By 2012, Prescribing Pharmacists Could Influence $145 Billion in Drug Sales 2
Transcranial vascular DWL doppler....
... Imexlab 9100SV is an automated system ... vascular tests. User definition of many of ... exam protocol to your patients' and staffs' ... comprehensive list of automated tests can easily ...
... 3000DX bidirectional vascular testing system offers ... the physician concerned with arterial and ... and made by Nicolet Vascular, the ... systems chosen by thousands of vascular ...
The CD Horizon M8 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
Medicine Products: